Chylomicron Disorders
Chylomicron Disorders is a lipid metabolism disorder characterized by the abnormal production, processing, or clearance of chylomicrons, leading to pathological accumulations of these lipoprotein particles in the bloodstream.
117
Publications
6K
Citations
630
Authors
210
Institutions
Publications per year
2017–2026
30
Parents
117
Ruth McPherson, Carl Mann, Alan R. Tall et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1991 · 215 citations
Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study
Leon A. Simons, Tiffany Dwyer, J. Simons et al. · Atherosclerosis · 1987 · 206 citations
Medicine, Cardiology, Endocrinology +15
1–5 of 117
630
12
h-index
8
h-index
7
h-index
6
h-index
5
h-index
1–5 of 630
210
Université de Montréal
Montreal, Canada
12 h-index
31 publications
2K citations
Akebia Therapeutics (United States)
Cambridge, United States
9 h-index
20 publications
3K citations

Western University
London, Canada
7 h-index
20 publications
1.2K citations

University of Cape Town
Rondebosch, South Africa
7 h-index
11 publications
1K citations
Université du Québec à Chicoutimi
Saguenay, Canada
6 h-index
24 publications
616 citations
University of California San Diego
San Diego, United States
6 h-index
7 publications
1.8K citations
Inserm
Paris, France
6 h-index
19 publications
656 citations

Amsterdam UMC Location University of Amsterdam
Amsterdam, The Netherlands
6 h-index
7 publications
1.1K citations
1–8 of 210
14 publications · 780 citations
14
h-index
10 publications · 499 citations
10
h-index
Repository · 8 publications · 159 citations
8
h-index
7 publications · 339 citations
7
h-index
CCA · 5 publications · 129 citations
5
h-index
1–5